Results 281 to 290 of about 2,328,855 (357)

Cannabidiol for Orofacial and Upper-Quarter Pain: A Systematic Evaluation of Therapeutic Potential. [PDF]

J Clin Med
Walczyńska-Dragon K, Fiegler-Rudol J, Nitecka-Buchta A, Baron S.   +3 more
europepmc   +1 more source

Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases. [PDF]

Pharmacol Rep
Szpręgiel I, Bysiek A.
europepmc   +1 more source

Further Optimization of the mGlu₁ PAM VU6024578/BI02982816: Discovery and Characterization of VU6033685. [PDF]

ACS Chem Neurosci
Reed CW, Kalbfleisch JF, Turkett JA, Trombley TA, Spearing PK, Haymer DH, Quitalig M, Dickerson JW, Foster DJ, Blobaum AL, Boutaud O, Cho HP, Niswender CM, Rook JM, Priepke H, Sommer H, Scheuerer S, Ursu D, Conn PJ, Melancon BJ, Lindsley CW.   +20 more
europepmc   +1 more source

Genetic disruption of leucine rich repeat transmembrane protein 4 like 1 induces a pro-social behavioural phenotype in zebrafish

Hillman C, Petracco G, Fontana BD, Scaia MF, Dalla-Vecchia E, Wetton JH, Norton WH, Parker M, Reichmann F.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

A metabotropic receptor for glycine

Nature Reviews Neuroscience, 2023
Darran M. Yates
semanticscholar   +3 more sources

Metabotropic glutamate receptors

Cell and Tissue Research, 2006
Metabotropic glutamate receptors (mGlus) are a family of G-protein-coupled receptors activated by the neurotransmitter glutamate. Molecular cloning has revealed eight different subtypes (mGlu1-8) with distinct molecular and pharmacological properties. Multiplicity in this receptor family is further generated through alternative splicing. mGlus activate
Ferraguti F., Shigemoto R.
openaire   +3 more sources